Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue , 1993, Pages 153-162

  Bradbury, F ^a  

^a ICON PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE;

ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; BRONCHITIS; CHRONIC BRONCHITIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZITHROMYCIN; BACTERIAL INFECTIONS; BRONCHITIS; CLARITHROMYCIN; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; FEMALE; HUMAN; MALE; MIDDLE AGE; PNEUMONIA; RESPIRATORY TRACT INFECTIONS;

EID: 0027202077     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/31.suppl_E.153     Document Type: Article

References (15)

1. Balmes, P., Clcrc, G., Dupont, B., Labram, C, Parientc, R. & Poirier, R. (1991). Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections. European Journal of Clinical Microbiology and Infectious Diseases 10, 437-9.
2. Chin, N. X., Neu, N. M., Labtharikul, P., Sana, G. & Neu, H. C. (1987). Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 31, 463-6.
3. Dark, D. (1991). Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. American Journal of Medicine 91, Suppl. 3A. 31S-5S.
4. Dunkin, K. T., Jones, S. & Howard, A. J. (1988). The in-vitro activity of CP-62, 993 against Haemophilia influenzae, Branhamella catarrhcdis, staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 21, 405-11.
5. Felmingham, D., Robbins, M. J., Sanghrajka, M., Leaky, A. & Ridgway, G. L. (1991). The invitro activity of some 14-, 15-and 16-membered macrolides against Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum. Drugs under Experimental and Clinical Research 17, 91-9.
6. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C, McDonald, E. J. & Fernandes, P. B. (1988). Comparative in-vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 32, 1710-9.
7. Kinasewitz, G. & Wood, R. G. (1991). Azitnromycin versus cefaclor treatment of acute bacterial pneumonia. European Journal of Clinical Microbiology and Infectious Diseases 10, 872-7.
8. Landis, R. J., Heyman, E. R. & Koch, G. G. (1978). Average partial association in three-way contingency tables: a review and discussion of alternative tests. International Statistical Review 46, 237-54.
9. Machka, K., Braveny, I., Dabernat, H., Dornbusch, K., van Dyck, E., Kayser, F. H. et al. (1988). Distribution and resistance patterns of Haemophitus influenzar. a European cooperative study. European Journal of Clinical Microbiology and Infectious Diseases 7, 14-24.
10. Ncu, H. C. (1991). The development of macrolides: clarithromycin in perspective. Journal of Antimicrobial Chemotherapy 27, Suppl. A, 1-9.
11. Retsema, J. A., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G. et al. (1987). Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrobial Agents and Chemotherapy 31, 1939-47.
12. Saito, A., Yamaguchi, K., Shigeno, Y., Kohno, S., Shigeno H., Kusano, N. et al. (1986). Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections. Drugs 31, Suppl. 3, 87-92.
13. SAS Institute. (1990). SAS/STAT User's Guide, Version 6, Volume 1, 4 edn, pp. 873-7. SAS Institute Inc., Cary, NC.
14. Vogel, F. (1991). Efficacy and tolerability of clarithromycin in the short-course treatment of acute respiratory tract infections. Drug Investigation 3, 205-9.
15. Washington J. A. & Wilson W. R. (1985). Erythromycin: a microbial and clinical perspective after 30 years of clinical use. Mayo Clinic Proceedings 60, 271-8